title: Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply.
authors: C
authors: C
authors: Reenaers
authors: E
authors: E
authors: Louis
authors: J
authors: J
authors: Belaiche
authors: L
authors: L
authors: Seidel
authors: S
authors: S
authors: Keshav
authors: S
authors: S
authors: Travis
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha